MAIA Biotechnology, Inc. Research And Development Expense

Quick Answer

MAIA Biotechnology, Inc. reported Research And Development Expense of $10.01 million for the year ending 2024.

  • MAIA Biotechnology, Inc. showed a decrease of -9.9% in Research And Development Expense from 2023 to 2024.
  • This data is from MAIA Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on March 21, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), MAIA Biotechnology, Inc.'s Research And Development Expense has grown by 186.2%.
  • Historical annual values: Fiscal year 2024: $10.01 million | Fiscal year 2023: $11.11 million | Fiscal year 2022: $8.93 million | Fiscal year 2021: $3.50 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: